Editorial Comment on Efficacy of Docetaxel Addition to Next-Generation Androgen Receptor-Axis-Targeted Therapies and Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer: A Tumor Volume-Specific Analysis.
사설/논평
0/5 보강
APA
Arai S (2025). Editorial Comment on Efficacy of Docetaxel Addition to Next-Generation Androgen Receptor-Axis-Targeted Therapies and Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer: A Tumor Volume-Specific Analysis.. International journal of urology : official journal of the Japanese Urological Association, 32(9), 1288-1289. https://doi.org/10.1111/iju.70208
MLA
Arai S. "Editorial Comment on Efficacy of Docetaxel Addition to Next-Generation Androgen Receptor-Axis-Targeted Therapies and Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer: A Tumor Volume-Specific Analysis.." International journal of urology : official journal of the Japanese Urological Association, vol. 32, no. 9, 2025, pp. 1288-1289.
PMID
40838607 ↗
같은 제1저자의 인용 많은 논문 (3)
- Editorial Comment on Preliminary Report on the Efficacy and Safety of Triplet Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer: YUSHIMA Study.
- Experimental Study of Microvascular Anastomosis: Comparison of the Conventional Method, Back Wall Technique, and Untied Stay Suture Method.
- Selection process for botulinum toxin injections in patients with chronic-stage hemiplegic stroke: a qualitative study.